Press Releases June 4, 2026 04:56 PM

FutureCorp Space Acquisition 1 Announces Pricing of $200,000,000 Initial Public Offering

FutureCorp Space Acquisition 1 prices $200 million IPO focused on space economy ventures

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
FTRAU

FutureCorp Space Acquisition 1 has priced its initial public offering of 20 million units at $10 each, expected to begin trading on the NYSE under ticker symbol FTRAU. Each unit includes one Class A ordinary share and half a redeemable warrant, focusing on leveraging acquisitions in the global space economy and adjacent industries.

FutureCorp Space Acquisition 1 Announces Pricing of $200,000,000 Initial Public Offering
FTRAU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • IPO of 20 million units priced at $10 each, raising $200 million with additional 3 million units overallotment option.
  • The company is a blank check (SPAC) targeting mergers or acquisitions in space economy sectors including manufacturing, telecommunications, and defense.
  • Units will separate into shares (FTRA) and warrants (FTRAW) trading on the NYSE post-IPO closing.
  • Sectors impacted include aerospace, satellite communications, defense, and advanced manufacturing within the space economy.

New York, NY, June 04, 2026 (GLOBE NEWSWIRE) -- FutureCorp Space Acquisition 1 (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The New York Stock Exchange LLC (“NYSE”) and begin trading on June 5, 2026, under the ticker symbol “FTRAU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NYSE under the symbols “FTRA” and “FTRAW,” respectively. The offering is expected to close on June 8, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments, if any.

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution. The Company’s primary focus will be on companies in the global space economy and adjacent industries, including space manufacturing and component supply chains, launch platforms, in-orbit services and habitats, in-orbit computing and manufacturing, space-based telecommunications and Earth observation, and defense-related activities.

The Company’s management team is led by Joshua B. Marks, its Chief Executive Officer and Chief Financial Officer, Matthew A. Long, the General Counsel, and Sudhin R. Shahani, the Chairman of the Board of Directors (the “Board”). The Board also includes David J. Anderman, Shawn K. Pelsinger, and John R. Tuttle.

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, New York, NY 10022, or by email at prospectus@cantor.com, or by accessing the SEC’s website, www.sec.gov.

A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (“SEC”) and became effective on June 4, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the expected closing of the proposed initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all.

Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. Copies of these documents are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor Contacts

FutureCorp Space Acquisition I
desk@futurecorp.vc
Attn: Joshua B. Marks; Sudhin R. Shahani


Risks

  • Completion of the IPO and subsequent business combination is uncertain and subject to market and regulatory conditions.
  • The company has yet to identify a target acquisition, creating execution risk inherent to SPAC vehicles.
  • Market volatility or changes in investor interest in space-related industries could impact stock liquidity and valuation post-IPO.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026